Nurturing talent in the School of Life Sciences
Translation and Commercialisation Support Group
A Translation and Commercialisation Support Group (TransComm) was established in 2018 with 10 core members and expertise spanning commercialisation, technology-transfer, innovation funding, entrepreneurship and life sciences/biotech. The group is Chaired by Dr Paul Davies.
The group is made up of key Principal investigators and professional services staff. This team constantly scans for spin-out opportunities and helps scientists wanting to commercialise to obtain the right advice and help at the right time. This proactive mechanism is key to translating discovery science into spinout and licensing opportunities.
The TransComm group coordinates Venture Capital Funder visits, linking interests of funders with projects requiring investment.
If you have an idea for translation and/or commercialisation activity you want to pursue, please contact them at: SLS-CommercialisationGroup@dundee.ac.uk
The Dundee Centre for Entrepreneurship operates a number of initiatives to support the entrepreneurial potential of staff, students and recent graduates. They offer the help of local business experts, who provide training, mentoring, inspirational talks and competitions with associated prize funding. One scheme, the Dundee Accelerator Programme assists early-stage businesses to improve their business offering, growth and investment potential. The Centre also provides pathways for Scottish-wide schemes including Converge Challenge and Scottish Edge, where several Life Sciences staff have enjoyed success at the start of their business endeavours. Examples include Platinum Informatics, TenBio Ltd and Tay Therapeutics (formally In4Derm).
Regional Innovation Hub
A new Regional Innovation Hub will anchor and support the scale up of new life sciences companies in Dundee. Created through the Tay Cities Deal, the new build will cover 4,700sqm over three storeys and will be located adjacent to city campus.
The hub will help catalyse inward investment into spin-out companies to enable them to grow. These companies will deliver new therapeutics, technologies, diagnostics for public benefit.
Opening in 2025.
The University has a team of experts to support our staff and students. Their knowledge, skills and facilities can support springboard ideas with market potential and bring business ambitions to fruition.